Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL... you obviously don't know what "FUD" means, even though you spew it daily. Go ask Mikey for help.
Why don't you buy shares of SAVA and ANVS so you can't copy and past your silly rants over there, too.
It's quite possible we could see Rett Excellence TLR this month and the peer-reviewed journal detailing AD & PDD data published during CTAD. It would be well played if that's the plan.
Though, The Rett TLR could also come after the journal... not much difference.
Another FUDster coming to the defense of his fellow cabal soldiers.
https://www.griproom.com/fun/how-to-spot-fake-comments-on-stock-boards
I stand by the facts and truth. All else, including your nonsense, is just FUD noise.
Here, again, are the facts of a successful AD trial...
ANAVEX®2-73 (blarcamesine) Meets Co-Primary and Key Secondary Endpoints for Patients with Early Alzheimer’s Disease
• Odds Ratio of ADAS-Cog meaningful improvement in cognition at threshold of -0.5 points or less (90% CI) 1.839 (1.17, 2.94) P = 0.015
• Odds Ratio of ADCS-ADL meaningful improvement in function at threshold of +3.5 points or higher (90% CI) 2.67 (1.17, 6.13) P = 0.0255
• ANAVEX®2-73 treatment slowed cognitive decline by 45% compared to placebo at 48 weeks
• Mean difference in ADAS-Cog score change of -1.85 points
• Compared to placebo, ANAVEX®2-73 (blarcamesine) reduced clinical decline of cognition and function by 27% with mean score difference of -0.42 points (p=0.040) as measured by CDR-SB
Manipulation before news...
What a joke you are... spewing nothing but complete FUD BS.
You obviously are well versed in collusive manipulation... and just need to fess up, FUDster.
Seems you either need a lesson in collusive manipulation... or just fess up.
I should probably cancel my .70 ask.
...meaning they exploit the FTD loopholes.
If shares had IDs or blockchain to validate them... and require all shorted shares to be delivered. But that ain't happening.
Yeah... the undeniable fact that you're a cabal soldier with loads of FUD ammo.
That's the problem... fraudulent phantom shares created by illegal naked shorting don't have to cover; they don't exist.
Nothing personal, but hope you have to chase.
Full disclosure... I've been "spoofing" with sell orders 5c and 10c higher, then cancel them when the price gets close. Am I in trouble?
LOL, nice try.
It's called "confirmation bias" and it's a real thing.
But, hey, I'm as hopeful as the next guy!
Agreed... Otherwise, NWBO would've requested the new 30-day review, in its PR, rather than 150.
If they intend to submit by Sept 25th, seems they would've said 25-40 days, in their PR, instead of 30-45 days, which 30 days comes slightly after the deadline.
Therefore, both NWBO and MHRA knows the date of submission. It would be silly if they didn't make the September 25th deadline.
That was entertaining... you venturing into the lion's den ill informed and getting chewed up and spit out... Ouch!
It's quite obvious 'your' not.
Is that the best FUD line your handlers can provide?
It was a no-brainer to reload, at .50 and .45, all the shares previously sold at around .75.
The difference being, most have to anticipate the expected manipulation, since we don't have access to the "script" like you do.
He thinks he's done DD on NWBO, but clearly is missing the boat.
Cabal soldier with FUD mouthpiece.
It helps having access to the cabal's script, right?
Your DD is quite lacking...
NWBO has, at least to date, never had the goods: its therapy is only marginally effective and has been commercially unsuccessful IMO.
Yep... same manipulation tactic being applied here, complete with a choir of FUDsters.
Your handlers better start covering... approval and commercialization next year!
Just a dead-cat bounce for NVCR.
Indeed... and will certainly bolster its lawsuit against the 7 HFs, substantiating its claim as an effective new cancer treatment.
FUDster who said AVXL won't be filing marketing applications, said the same about NWBO...
https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-completion-of-prerequisites-and-plans-for-submission-of-marketing-authorization-application-301912602.html
NWBO is now on an official countdown to MA and commercialization. Better tell your handlers to cover their short positions.
LOL... the FUD seagull arrives on cue.
Boldface FUD lie...
He NEVER hits a Date
Weren't you paying attention when Missling clearly stated that Rett results will be provided in this half? And his intent is to surprise the cabal... err market.
FYI, it'll be this half until 12/31, but I'm confident the surprise will come well before then.
Your posts are absolute FUD BS!
Other points of emphasis...
The ANAVEX®2-73 Phase 2b/3 study design incorporates genomic precision medicine biomarkers identified in the ANAVEX®2-73 Phase 2a study. ANAVEX®2-73 Phase 2a Alzheimer’s disease study previously demonstrated dose dependent improvement in exploratory endpoints of cognition (MMSE) and function (ADCS-ADL).
Unfortunately, there's no cure for what you suffer.
If Missling didn't believe that an approval pathway is forthcoming, he wouldn't be talking commercialization nor would he mention the possibility of the AD OLE serving as the confirmatory trial. He likely has had conversations with the FDA about it for him to make such a statement.
I've been an investor/trader here for over 8 years... and have experienced all the nonsense FUDing and short attacks on excellent news/results.
We know who the cabal soldiers are...